2014 fda drug approvals

47
36 DRUGS 10 COMPANIES DRUGS 2014 YEAR IN REVIEW FDA DRUG APPROVALS Novel Drugs Approved in 2014 APPROVED

Upload: perficient-inc

Post on 11-Jul-2015

743 views

Category:

Technology


5 download

TRANSCRIPT

Page 1: 2014 FDA Drug Approvals

36 DRUGS

10 COMPANIESDRUGS

2014 YEAR IN REVIEW

FDADRUG APPROVALS

Novel Drugs Approved in 2014

APPROVED

Page 2: 2014 FDA Drug Approvals

Type 2 Diabetes

Source: FDA.GOV

FARXIGA 1

Page 3: 2014 FDA Drug Approvals

Non­24­Hour Sleep­Wake Disorder

Source: FDA.GOV

HETLIOZ 2

Page 4: 2014 FDA Drug Approvals

Morquio A Syndrome

Source: FDA.GOV

VIMIZIM 3

Page 5: 2014 FDA Drug Approvals

Neurogenic Orthostatic Hypotension(NOH)

Source: FDA.GOV

NORTHERA 4

Page 6: 2014 FDA Drug Approvals

Complications of Leptin Deficiency

Source: FDA.GOV

MYALEPT 5

Page 7: 2014 FDA Drug Approvals

Positron Emission Tomography (PET)Imaging of the Brain

Source: FDA.GOV

NEURACEQ 6

Page 8: 2014 FDA Drug Approvals

Leishmaniasis

Source: FDA.GOV

IMPAVIDO 7

Page 9: 2014 FDA Drug Approvals

Moderate to Severe Plaque Psoriasis

Source: FDA.GOV

OTEZLA 8

Page 10: 2014 FDA Drug Approvals

Type 2 Diabetes

Source: FDA.GOV

TANZEUM 9

Page 11: 2014 FDA Drug Approvals

Advanced Stomach Cancer orGastroesophageal JunctionAdenocarcinoma

Source: FDA.GOV

CYRAMZA 10

Page 12: 2014 FDA Drug Approvals

Multicentric Castleman’s Disease (MCD)

Source: FDA.GOV

SYLVANT 11

Page 13: 2014 FDA Drug Approvals

Anaplastic Lymphoma Kinase­Positive(ALK+) Metastatic Non­Small Cell LungCancer (NSCLC)

Source: FDA.GOV

ZYKADIA 12

Page 14: 2014 FDA Drug Approvals

Reduce Risk of Heart Attacks and Stroke inHigh­Risk Patients

Source: FDA.GOV

ZONTIVITY 13

Page 15: 2014 FDA Drug Approvals

Severe Ulcerative Colitis and AdultPatients with Moderate to Severe Crohn‘sDisease

Source: FDA.GOV

ENTYVIO 14

Page 16: 2014 FDA Drug Approvals

Acute Bacterial Skin and Skin StructureInfections

Source: FDA.GOV

DALVANCE 15

Page 17: 2014 FDA Drug Approvals

Toenail Fungus

Source: FDA.GOV

JUBLIA 16

Page 18: 2014 FDA Drug Approvals

Acute Bacterial Skin and Skin StructureInfections

Source: FDA.GOV

SIVEXTRO 17

Page 19: 2014 FDA Drug Approvals

Peripheral T­Cell Lymphoma (PTCL)

Source: FDA.GOV

BELEODAQ 18

Page 20: 2014 FDA Drug Approvals

Toenail Fungus

Source: FDA.GOV

KERYDIN 19

Page 21: 2014 FDA Drug Approvals

Chronic Lymphocytic Leukemia (CLL)Follicular B­cell non­Hodgkin Lymphoma(FL)Small Lymphocytic Lymphoma (SLL)

Source: FDA.GOV

ZYDELIG 20

Page 22: 2014 FDA Drug Approvals

Chronic Obstructive Pulmonary Disease(COPD)

Source: FDA.GOV

STRIVERDIRESPIMAT

21

Page 23: 2014 FDA Drug Approvals

Type 2 Diabetes

Source: FDA.GOV

JARDIANCE 22

Page 24: 2014 FDA Drug Approvals

Type 2 Diabetes

Source: FDA.GOV

ORBACTIV 23

Page 25: 2014 FDA Drug Approvals

Insomnia

Source: FDA.GOV

BELSOMRA 24

Page 26: 2014 FDA Drug Approvals

Relapsing Forms of Multiple Sclerosis (MS)

Source: FDA.GOV

PLEGRIDY 25

Page 27: 2014 FDA Drug Approvals

Gaucher Disease Type 1

Source: FDA.GOV

CERDELGA 26

Page 28: 2014 FDA Drug Approvals

Melanoma

Source: FDA.GOV

KEYTRUDA 27

Page 29: 2014 FDA Drug Approvals

Opioid­Induced Constipation (OIC) in AdultPatients with Chronic Non‑Cancer Pain

Source: FDA.GOV

MOVANTIK 28

Page 30: 2014 FDA Drug Approvals

Type 2 Diabetes

Source: FDA.GOV

TRULICITY 29

Page 31: 2014 FDA Drug Approvals

Type 2 Diabetes

Source: FDA.GOV

LUMASON 30

Page 32: 2014 FDA Drug Approvals

Nausea and Vomiting in PatientsUndergoing Cancer Chemotherapy

Source: FDA.GOV

AKYNZEO 31

Page 33: 2014 FDA Drug Approvals

Chronic Hepatitis C

Source: FDA.GOV

HARVONI 32

Page 34: 2014 FDA Drug Approvals

Idiopathic Pulmonary Fibrosis (IPF)

Source: FDA.GOV

ESBRIET 33

Page 35: 2014 FDA Drug Approvals

Idiopathic Pulmonary Fibrosis (IPF)

Source: FDA.GOV

OFEV 34

Page 36: 2014 FDA Drug Approvals

Acute Lymphoblastic Leukemia

Source: FDA.GOV

BLINCYTO 35

Page 37: 2014 FDA Drug Approvals

Otitis Externa (Swimmer's Ear)

Source: FDA.GOV

XTORO 36

Page 38: 2014 FDA Drug Approvals

Advanced Ovarian Cancer

Source: FDA.GOV

LYNPARZA 37

Page 39: 2014 FDA Drug Approvals

Chronic Genotype 1 Hepatitis C

Source: FDA.GOV

VIEKIRA PAK 38

Page 40: 2014 FDA Drug Approvals

COMPLICATED URINARY TRACT ANDCOMPLICATED INTRA­ABDOMINALINFECTIONS

Source: FDA.GOV

ZERBAXA 39

Page 41: 2014 FDA Drug Approvals

Acute Uncomplicated Influenza

Source: FDA.GOV

RAPIVAB 40

Page 42: 2014 FDA Drug Approvals

Advanced Melanoma

Source: FDA.GOV

OPDIVO 41

Page 43: 2014 FDA Drug Approvals

Chronic Weight Management

Source: FDA.GOV

SAXENDA 42

Page 44: 2014 FDA Drug Approvals

Chronic Lymphocytic Leukemia

Source: FDA.GOV

IMBRUVICA 43

Page 45: 2014 FDA Drug Approvals

Type 2 Diabetes

Source: FDA.GOV

INVOKAMET 44

Page 46: 2014 FDA Drug Approvals

Inflammatory Lesions, Bumps andPimples, of Rosacea

Source: FDA.GOV

SOOLANTRA 45

Page 47: 2014 FDA Drug Approvals

36 DRUGS

10 COMPANIES

DRUGS

CREATED BY: